Articles tagged with Pancreatic Cancer
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A combination of chemotherapy drugs showed improved overall and progression-free survival rates compared to a single drug, gemcitabine. Patients treated with the combination regimen (PEGF) had a higher percentage alive without disease after 4 months than those on standard treatment.
Metal stents have been shown to be a safe and effective treatment for bile duct obstructions caused by pancreatic cancer. The study found that 90% of patients had open stents after three months and 80% after one year, with minimal complications.
A large cohort study found that high consumption of processed meats was associated with a significant increase in pancreatic cancer risk. The study, which followed over 190,000 participants, suggests that chemical reactions during meat preparation may be responsible for this link.
Researchers found that capsaicin, a compound in red chili pepper, exhibited anticancer activity against pancreatic cancer cells. Phenethyl isothiocyanate (PEITC), a constituent of cruciferous vegetables like broccoli, also showed therapeutic benefits in inhibiting ovarian cancer cell growth.
A Harvard School of Public Health study analyzed dietary habits and found no strong association between western or prudent diets and pancreatic cancer risk. Participants who adhered to the prudent diet had healthier lifestyle behaviors, suggesting individual dietary components may still play a role in risk.
A new study found that altering food schedules and light/dark exposure in mice modified the expression of circadian clock genes and genes involved in carcinogenesis and tumor progression. The authors conclude that the altered light/dark or feeding schedules may slow tumor growth in chronic jet-lagged mice.
Researchers at Mayo Clinic discovered a new pathway against pancreatic cancer by targeting the GSK-3 Beta molecule, which regulates NF Kappa B activity. This finding may lead to new drug development strategies for other cancers and improve treatment options for pancreatic cancer patients.
Researchers are evaluating the effectiveness of BAY43-9006 alone and paired with gemcitabine in a phase II clinical trial for metastatic pancreatic carcinoma. The trial aims to add much-needed treatment options for this aggressive cancer, which affects approximately 27,000 deaths annually in the US.
A recent study published in Annals of Internal Medicine found that high-quality CT scans can accurately determine which pancreatic cancers are treatable, rendering endoscopic ultrasound unnecessary. The study also revealed that CT scans were more accurate in detecting new cancers and determining the stage of the disease.
Researchers found that patients with a family history of pancreatic cancer are more likely to be diagnosed at an earlier age and have a smoking history. The study suggests that strong counseling against smoking is necessary for these patients, as well as smoking cessation programs.
Researchers at Université de Montréal found that diabetes patients are three times more likely to develop liver cancer and twice as likely to get pancreatic cancer. The study analyzed data from over 3,000 cancer patients and healthy individuals.
Researchers found a three-fold increased risk of liver cancer among diabetic patients, which rose to almost four-fold when medication was used. Diabetes did not increase risks for other types of cancer, such as melanoma or colon cancer.
Researchers have made significant progress in developing a therapeutic vaccine for pancreatic cancer, which appears safe and stimulates immune activity. In a recent study, 12 patients with pancreatic cancer received the vaccine, resulting in no reported toxicity and positive changes in antibodies against the tumor.
Cohen's team found that fibroblast activation protein (FAP) and focal adhesion kinase (FAK) are overexpressed in over 90% of pancreatic adenocarcinomas, suggesting they may contribute to poor outcomes. However, selective inhibition of these proteins shows promise in preclinical models.
A study of 138,307 men found exclusive pipe smoking increased risk for six cancers and three diseases, with highest risk in larynx, lung, and oropharynx. Pipe smoking was associated with smaller but similar risks to cigar smoking, while larger than cigarette smoking.
Researchers from Michigan Medicine have discovered a protein biomarker and cell-signaling pathway that may aid in the detection and treatment of pancreatic cancer. The study found that a specific protein called CEACAM 1 is elevated in the blood of pancreatic cancer patients, allowing for better differentiation from normal tissue.
Researchers have made breakthroughs in understanding the molecular mechanisms driving pancreatic cancer's rapid growth and resistance to treatment. They've identified new targets for therapy, including a protein sponge that suppresses tumor growth and a novel mechanism for chemoresistance.
Researchers found that administering opioid growth factor (OGF) to patients with advanced pancreatic cancer improved their quality of life and survival rates. OGF was shown to be non-toxic and did not cause common side effects associated with chemotherapy, such as hair loss or nausea.
A study found that the anti-inflammatory drug nimesulide triggered angiogenesis and increased pancreatic cancer cell growth in COX-2 negative tumor cells, but inhibited tumor growth in COX-2 positive cells. Researchers plan to test other COX-2 inhibitors for similar effects.
A Mayo Clinic study of 100 patients with advanced pancreatic cancer found that a nerve block technique, combined with pain-relieving medications, provided a 50% reduction in pain and improved quality of life. The study suggests that this treatment option could be beneficial for patients with pancreatic cancer, allowing them to live mor...
A study of over 88,000 women found no significant difference in pancreatic cancer risk between aspirin users and non-users. However, extended regular aspirin use was associated with a 58% increased risk, while higher doses were linked to an 86% increased risk.
A new animal model of pancreatic cancer has been developed, which mimics both non-invasive and invasive forms of the disease. The study identified a unique protein signature in the blood of animals with precancerous lesions, offering potential for early detection and therapeutic targets.
Researchers have developed a mouse model that mimics human pancreatic cancer, enabling the discovery of biomarkers for early detection and potential therapeutic targets. The model replicates the disease's progression and is poised to facilitate rapid testing of novel treatments.
Researchers have made significant progress towards a vaccine for pancreatic cancer, with one patient out of ten remaining disease-free after five years and two others surviving over two years. While the study's findings are promising, caution is advised due to the small sample size and potential biases in the selection process.
Researchers found that pancreatic cancer growth can be arrested by blocking the Hedgehog signaling pathway, which is active in human embryonic development. This pathway has been linked to several other types of cancer and may offer a new treatment avenue for pancreatic cancer.
Researchers at Johns Hopkins Medicine found that pancreatic cancer may be triggered by the reactivation of a growth signal normally turned off in adult tissues. By blocking this pathway, they hope to prevent the early cellular changes leading to cancer.
Researchers at Michigan Medicine have identified 158 genes specific to pancreatic cancer in a new study, providing a more accurate accounting of the disease's molecular makeup. The team hopes to use this knowledge to develop new diagnostic tests and treatments tailored to individual patients.
Researchers have identified a genetic link between Fanconi's Anemia and pancreatic cancer, finding that faulty FA-related genes can make cancer cells susceptible to certain treatments. This discovery may lead to improved treatment options for patients with early-onset pancreatic cancer caused by gene mutations.
Researchers identified BRCA2 germline mutations in 19% of families with familial pancreatic cancer. The presence of specific frameshift mutations was found in 12% of the families studied. These findings suggest an important role for BRCA2 mutations in a subpopulation of families with familial pancreatic cancer.
A study suggests that a high-starch diet may increase the risk of pancreatic cancer in overweight and sedentary women. Women with diets heavy in starchy foods were found to be more than two-and-a-half times more likely to develop pancreatic cancer than those with low glycemic loads.
A study found no association between carbohydrate and sucrose intake and pancreatic cancer risk, but a diet high in glycemic load increased the risk among overweight women. Dairy product consumption was not associated with reduced breast cancer risk among postmenopausal women, but may be protective in premenopausal women.
A study of over 7 years found that women taking aspirin two to five times per week had a lower risk of pancreatic cancer compared to those not taking it. The researchers estimate that aspirin use might prevent up to 43% of pancreatic cancer cases in women who do not normally take aspirin.
Researchers found that MMP-9 expression contributes to angiogenesis in human ovarian tumors, while dense breasts compromise diagnostic mammography sensitivity. Aspirin users have a lower risk of developing pancreatic cancer, according to the study.
The study demonstrated that gemcitabine was well-tolerated in patients with superficial bladder cancer, with no or very low levels of the drug found in plasma samples. The results suggest that gemcitabine may be a suitable alternative to current standard treatments, which often cause toxic side effects.
A large family study identified a specific genetic marker on chromosome 4 associated with inherited pancreatic cancer. The discovery sheds light on the disease's development and may lead to new prevention and treatment strategies.
Researchers have identified a region of chromosome 4 associated with pancreatic cancer, which may lead to earlier identification and treatment. The discovery has potential implications for understanding the disease's causes and developing new treatments.
African-American patients with non-small-cell lung cancer have a significantly lower one-year survival rate compared to non-African-American patients. Despite similar disease stages and health care disparities, researchers found no difference in outcomes after adjusting for factors such as performance status and socioeconomic status.
Researchers investigate DNA repair capacity and its association with melanoma risk, while also exploring the predictive value of HPV testing in managing equivocal Pap tests. Additionally, a study on breast cancer biomarkers finds that measuring uPA and PAI-1 levels may help predict disease course and inform treatment strategies.
Researchers at Columbia University Irving Medical Center have discovered a combination of two genes that selectively kill pancreatic cancer cells in test tube experiments. The mda-7 protein and K-ras antisense DNA combination prevents tumor growth in animals, offering a potential new treatment option for this aggressive disease.
A clinical trial found that marimastat produced comparable one-year survival rates to chemotherapy drug gemcitabine in patients with localized pancreatic cancer. Fewer toxic side effects were reported in patients taking marimastat compared to gemcitabine.
A long duration of regular aspirin use is associated with a significant increase in pancreatic cancer risk among women. Women taking 14 or more tablets per week experience nearly an 86% increased risk, while those taking six to 13 tablets per week see a 41% higher risk.
A new pancreatic cancer vaccine has been found to be safe and successful in reaching immune system cells, with several patients remaining disease-free over 30 months after diagnosis. The vaccine uses lab-grown pancreatic cancer cells genetically-modified with the immune-boosting gene GM-CSF.
A new study by Northwestern University Medical School researchers found that high blood sugar levels are associated with an increased risk of pancreatic cancer death. The study analyzed data from nearly 40,000 men and women who were screened for cardiovascular disease risk and followed up for an average of 25 years.
The Seattle Gastrointestinal Program Project will investigate the role of oxidative damage in pancreatitis and chronic ulcerative colitis. Researchers aim to develop screening tests for pancreatic cancer and more sensitive early detection methods for colon cancer.
Researchers found that tumors with a specific BRCA2 mutation are more sensitive to radiation and certain chemotherapy drugs. This suggests genetic screening could be used to tailor treatment for patients with this mutation, potentially improving outcomes.
Researchers at Ohio State University have developed a technique to help surgeons determine the extent of tumor spread in pancreatic cancer patients. This method uses an antibody labeled with radioactivity to detect cancer cells, potentially improving treatment outcomes and reducing harm from extensive surgery.
Researchers found that patients who received chemotherapy and radiation after surgery lived longer than those who did not. Additionally, 7% of patients had inherited mutations in the BRCA2 gene, which is linked to breast and ovarian cancer.
Researchers are testing a promising new vaccine against pancreatic cancer, which boasts one of cancer's poorest survival rates. The vaccine targets an abnormal variant of the ras gene, designed to stimulate an immune response against mutant ras protein.